The sale of diet drug rimonabant (Acomplia / Zimulti) during the period of first three months of 2007 were 15 million Euros which was not a satisfactory sale of the expensive Weight Loss diet pill. European refusal of repayment of insurance affected the sale of the Weight Loss Pill. According to Sanofi more than 130,000 overweight and obese people have consumed the weight loss pill in Europe